Myopathy associated with lipid lowering therapy in patients with previously undiagnosed or undertreated hypothyroidism.
作者信息
Lang J E, Wang P, Glueck C J
机构信息
Cholesterol Center, Jewish Hospital, Cincinnati, Ohio 45229, USA.
出版信息
Clin Chim Acta. 1996 Oct 15;254(1):65-92. doi: 10.1016/0009-8981(96)06376-0.
PMID:8894313
Abstract
摘要
相似文献
1
Myopathy associated with lipid lowering therapy in patients with previously undiagnosed or undertreated hypothyroidism.既往未诊断或治疗不足的甲状腺功能减退患者中与降脂治疗相关的肌病。
Clin Chim Acta. 1996 Oct 15;254(1):65-92. doi: 10.1016/0009-8981(96)06376-0.
2
Long-term safety and efficacy of combination gemfibrozil and HMG-CoA reductase inhibitors for the treatment of mixed lipid disorders.吉非贝齐与HMG-CoA还原酶抑制剂联合治疗混合性血脂异常的长期安全性和疗效。
Am Heart J. 1999 Jul;138(1 Pt 1):151-5. doi: 10.1016/s0002-8703(99)70261-9.
3
Frequency of creatine kinase elevation during treatment with fluvastatin in combination with fibrates (bezafibrate, fenofibrate, or gemfibrozil).
Am J Cardiol. 2003 Jan 15;91(2):238-40. doi: 10.1016/s0002-9149(02)03116-8.
4
5
Rhabdomyolysis associated with simvastatin-gemfibrozil therapy.与辛伐他汀-吉非贝齐联合治疗相关的横纹肌溶解症。
South Med J. 1997 May;90(5):546-7. doi: 10.1097/00007611-199705000-00018.
6
Variable influence of statins on isoprostanes in hyperlipidemia.
Adv Exp Med Biol. 2003;525:209-12. doi: 10.1007/978-1-4419-9194-2_45.
7
Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage.单独或联合使用氟伐他汀和吉非贝齐治疗混合性高脂血症不会引起肌肉损伤。
Am J Cardiol. 1995 Jul 13;76(2):126A-128A. doi: 10.1016/s0002-9149(05)80034-7.
8
Statin + fibrate combination therapy fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease.他汀类药物与贝特类药物联合治疗：氟伐他汀与苯扎贝特或环丙贝特用于血管疾病高危患者。
Int J Cardiol. 1999 Jun 1;69(3):237-44. doi: 10.1016/s0167-5273(99)00013-3.
9
Pharmacokinetics of the combination of fluvastatin and gemfibrozil.氟伐他汀与吉非贝齐联合应用的药代动力学
Am J Cardiol. 1995 Jul 13;76(2):80A-83A. doi: 10.1016/s0002-9149(05)80024-4.
10
Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate.高脂血症和动脉粥样硬化患者血浆血管内皮生长因子及其受体Flt-1以及氟伐他汀或非诺贝特的作用
Am J Cardiol. 2001 May 15;87(10):1160-3. doi: 10.1016/s0002-9149(01)01486-2.
引用本文的文献
1
Cardiovascular and medical ramifications of treatment of subclinical hypothyroidism.亚临床甲状腺功能减退治疗的心血管及医学影响
Curr Atheroscler Rep. 2003 Jan;5(1):73-7. doi: 10.1007/s11883-003-0071-5.
2
Drug interactions and the statins.药物相互作用与他汀类药物
CMAJ. 1999 Nov 16;161(10):1281-6.
3
Fluvastatin: a review of its use in lipid disorders.氟伐他汀：其在脂质紊乱治疗中的应用综述
Drugs. 1999 Apr;57(4):583-606. doi: 10.2165/00003495-199957040-00009.
Zotero 插件